Redx Pharma Share Price | |
---|---|
Price | 9.00 |
Bid | 5.00 |
Ask | 13.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 9.25 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 388.99m |
Market Capitalisation | £35.98m |
Market Size | 3,000 |
52 Week High | 36.00 |
52 Week High Date | 15-May-2023 |
52 Week Low | 4.25 |
52 Week Low Date | 05-Apr-2024 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -0.934343 |
Earnings | -9.90 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
24-Apr-24 | 16:38:04 | 9.153 | 110,575 | Unknown* | 8.50 | 10.00 | 10.12k | O Ordinary Delayed publication |
23-Apr-24 | 12:58:33 | 10.50 | 500,000 | Unknown* | 8.50 | 10.00 | 52.50k | O Ordinary Delayed publication Historical |
23-Apr-24 | 12:59:56 | 10.51 | 500,000 | Unknown* | 8.50 | 10.00 | 52.55k | O Ordinary Delayed publication Historical |
24-Apr-24 | 16:27:26 | 9.00 | 3,223 | Sell* | 8.50 | 10.00 | 290.07 | O Ordinary |
24-Apr-24 | 16:19:15 | 9.00 | 566 | Sell* | 9.00 | 10.00 | 50.94 | O Ordinary Trade was executed as an SI |
24-Apr-24 | 15:54:44 | 10.00 | 854 | Buy* | 9.50 | 10.00 | 85.40 | O Ordinary Trade was executed as an SI |
24-Apr-24 | 15:54:42 | 9.90 | 5,254 | Sell* | 9.50 | 10.50 | 520.15 | O Ordinary |
24-Apr-24 | 15:54:24 | 10.00 | 3,000 | Unknown* | 9.50 | 10.50 | 300.00 | O Ordinary |
24-Apr-24 | 15:54:25 | 10.50 | 952 | Buy* | 9.50 | 10.50 | 99.96 | O Ordinary Trade was executed as an SI |
24-Apr-24 | 15:54:25 | 9.50 | 130 | Sell* | 9.50 | 10.50 | 12.35 | O Ordinary Trade was executed as an SI |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
18-Apr-24 | 17-Apr-24 | Buy | Lisa Anson held the position of Chief Executive Officer at the time of this trade.Lisa Anson | 11.00 | GBX | 74,500 | 751,683 |
18-Apr-24 | 16-Apr-24 | Buy | Lisa Anson held the position of Chief Executive Officer at the time of this trade.Lisa Anson | 9.38 | GBX | 115,000 | 751,683 |
12-Apr-24 | 11-Apr-24 | Buy | Lisa Anson held the position of Chief Executive Officer at the time of this trade.Lisa Anson | 7.50 | GBX | 399,000 | 562,183 |
30-Sep-21 | 30-Sep-21 | Notification of Holding | Peter Presland held the position of Independent Non-Executive Director at the time of this trade.Peter Presland | 0.00 | 0 | 146,225 | |
30-Sep-21 | 30-Sep-21 | Notification of Holding | Sarah Gordon held the position of Independent Non-Executive Director at the time of this trade.Sarah Gordon | 0.00 | 0 | 892,858 |